ATGAM versus OKT3 induction therapy in cadaveric kidney transplantation: patient and graft survival, CD3 subset, infection, and cost analysis.

Source:http://linkedlifedata.com/resource/pubmed/id/9636549

Download in:

View as

General Info

PMID
9636549